Get the Stockscreener App
0.00
100.00%
-5.20
After Hours:
4.48
4.48
+
Tnf Pharmaceuticals Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms, Isomyosamine and Supera-CBD. Isomyosamine is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B. The company has one reportable segment focused on Isomyosamine.
See More
Previous Close:
$5.20
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$9.60M
Revenue:
-
Net Income/Loss:
$-23.66M
P/E Ratio:
0.00
EPS:
-13.84
Net Cash Flow:
$-10.14M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$158.00
Tnf Pharmaceuticals Inc Stock (TNFA) Company Profile
Name
Tnf Pharmaceuticals Inc
Sector
Industry
Phone
856-848-8698
Address
1185 AVENUE OF THE AMERICAS, NEW YORK
Compare TNFA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNFA
Tnf Pharmaceuticals Inc
|
0.00 | 9.60M | 0 | -23.66M | -10.14M | -13.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.96 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.36 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
851.42 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.17 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.67 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tnf Pharmaceuticals Inc Stock (TNFA) Latest News
How analysts rate TNF Pharmaceuticals Inc. stock today2025 Support & Resistance & Real-Time Stock Movement Alerts - Newser
Is TNF Pharmaceuticals Inc. (DQS0) stock considered safe havenTreasury Yields & Safe Swing Trade Setup Alerts - Newser
Aug Highlights: How analysts rate TNF Pharmaceuticals Inc stock todayEarnings Growth Summary & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Can TNF Pharmaceuticals Inc. (DQS0) stock sustain free cash flowWeekly Risk Report & High Yield Equity Trading Tips - Newser
How TNF Pharmaceuticals Inc. stock trades before earningsMarket Risk Summary & Technical Pattern Based Signals - Newser
Why global investors buy TNF Pharmaceuticals Inc. (DQS0) stockJuly 2025 Momentum & Fast Entry High Yield Stock Tips - Newser
How geopolitical risks impact TNF Pharmaceuticals Inc. (DQS0) stockBond Market & Daily Technical Forecast Reports - Newser
Why TNF Pharmaceuticals Inc. stock remains on watchlistsWeekly Investment Report & Low Drawdown Momentum Ideas - Newser
Will TNF Pharmaceuticals Inc. (DQS0) stock deliver stable dividendsJuly 2025 Breakouts & Smart Money Movement Tracker - Newser
Is TNF Pharmaceuticals Inc. (DQS0) stock in buy zone after pullbackMarket Weekly Review & Precise Swing Trade Alerts - Newser
Published on: 2025-12-02 04:51:35 - Newser
Published on: 2025-12-02 02:55:05 - Newser
What analysts say about TNF Pharmaceuticals Inc stockSector Rotation Strategies & High Yield Trading Signals - earlytimes.in
Can TNF Pharmaceuticals Inc. stock sustain market leadership2025 Volume Leaders & Reliable Price Breakout Signals - moha.gov.vn
How TNF Pharmaceuticals Inc. (DQS0) stock reacts to stronger dollarMarket Weekly Review & Momentum Based Trading Ideas - newser.com
Why TNF Pharmaceuticals Inc. stock is a value investor pickEarnings Risk Report & Precise Trade Entry Recommendations - newser.com
Will TNF Pharmaceuticals Inc. stock continue upward momentum2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
How TNF Pharmaceuticals Inc. stock performs during Fed tightening cyclesJuly 2025 Breakouts & Weekly High Return Opportunities - newser.com
Real time pattern detection on TNF Pharmaceuticals Inc. stockFed Meeting & Risk Managed Investment Entry Signals - newser.com
Is TNF Pharmaceuticals Inc. stock a defensive play in 2025 - newser.com
How to build a custom watchlist for TNF Pharmaceuticals Inc.Market Risk Analysis & Weekly High Potential Alerts - newser.com
Published on: 2025-11-19 16:28:17 - newser.com
Q/C TECHNOLOGIES, INC. SEC 10-Q Report - TradingView
Will TNF Pharmaceuticals Inc. stock recover faster than peersJuly 2025 Earnings & Precise Buy Zone Identification - newser.com
Why TNF Pharmaceuticals Inc. stock is seen as undervaluedJobs Report & AI Forecast Swing Trade Picks - newser.com
Is TNF Pharmaceuticals Inc. stock a buy on dipsEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Is TNF Pharmaceuticals Inc. (DQS0) stock a buy on weakness - newser.com
Does TNF Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Portfolio Report & Target Return Focused Picks - newser.com
Full technical analysis of TNF Pharmaceuticals Inc. stockJuly 2025 Technicals & Fast Moving Stock Watchlists - newser.com
Published on: 2025-11-18 23:18:39 - newser.com
Tnf Pharmaceuticals Inc Stock (TNFA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
1.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):